Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

Reverse left ventricular (LV) remodeling and recovery of LV function are associated with
improved clinical outcomes in patients with heart failure with reduced ejection fraction. A …

Cardiomyopathies are a heterogeneous group of heart muscle diseases and an important
cause of heart failure (HF). Current knowledge on incidence, pathophysiology and natural …

In response to injury, hemodynamic changes, or neurohormonal activation, the heart
undergoes a series of structural and functional changes that have been termed cardiac …

With a prevalence of 5.8 million in the United States alone, heart failure (HF) is associated
with high morbidity, mortality, and healthcare expenditures. Close to 1 million …

Despite available therapy, mortality and readmission rates within 60–90 days of discharge
for patients hospitalized with heart failure (HF) approach 15% and 30%, respectively. This …

Importance Heart failure (HF) guidelines recognize that a subset of patients with HF and
preserved left ventricular ejection fraction (LVEF) previously had reduced LVEF but …

Objectives: This study sought to evaluate the incidence, the predictors, and the associations
with outcomes of changes in ejection fraction (EF) in heart failure (HF) patients. Background …

ABSTRACT Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

In patients with heart failure, the beneficial effects of drug and device therapies counteract to
some extent ongoing cardiac damage. According to the net balance between these two …